Previous Article | Next Article 
J Virol. 1987 May; 61(5): 1310-1317
Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
A B Rickinson,
L S Young and
M Rowe
ABSTRACT
Epstein-Barr virus (EBV) isolates show sequence divergence in the BamHI YH region of the genome which encodes the nuclear antigen EBNA 2, a protein thought to be involved in the initiation of virus-induced B-cell transformation; type A isolates (such as B95-8 EBV) encode a 82- to 87-kilodalton EBNA 2A protein, whereas type B isolates (such as AG876 EBV) encode an antigenically distinct 75-kilodalton EBNA 2B protein. In the present work 12 type A isolates and 8 type B isolates have been compared for their ability to transform resting human B cells in vitro into permanent lymphoblastoid cell lines. Although the kinetics of initial focus formation was not markedly dependent upon the EBNA 2 type of the transforming virus, on subsequent passage type A virus-transformed cells (type A transformants) yielded cell lines much more readily than did type B transformants. Direct comparison between the two types of transformant revealed clear differences in several aspects of growth phenotype. Compared with type A transformants, cell lines established with type B virus isolates consistently displayed an unusual growth pattern with poor survival of individual cells shed from lymphoblastoid clumps, a lower growth rate and a greater sensitivity to seeding at limiting dilutions, and a significantly lower saturation density that could not be corrected by supplementation of the medium with culture supernatant containing B-cell growth factors. This is the first direct evidence that, in EBV-transformed B-cell lines, the EBNA 2 protein plays a continuing role in determining the cellular growth phenotype.
J Virol. 1987 May; 61(5): 1310-1317
This article has been cited by other articles:
-
Lucchesi, W., Brady, G., Dittrich-Breiholz, O., Kracht, M., Russ, R., Farrell, P. J.
(2008). Differential Gene Regulation by Epstein-Barr Virus Type 1 and Type 2 EBNA2. J. Virol.
82: 7456-7466
[Abstract]
[Full Text]
-
Carroll, K. D., Bu, W., Palmeri, D., Spadavecchia, S., Lynch, S. J., Marras, S. A. E., Tyagi, S., Lukac, D. M.
(2006). Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway. J. Virol.
80: 9697-9709
[Abstract]
[Full Text]
-
Zeng, M.-S., Li, D.-J., Liu, Q.-L., Song, L.-B., Li, M.-Z., Zhang, R.-H., Yu, X.-J., Wang, H.-M., Ernberg, I., Zeng, Y.-X.
(2005). Genomic Sequence Analysis of Epstein-Barr Virus Strain GD1 from a Nasopharyngeal Carcinoma Patient. J. Virol.
79: 15323-15330
[Abstract]
[Full Text]
-
Lin, J.-C., Cherng, J.-M., Lin, H.-J., Tsang, C.-W., Liu, Y.-X., Lee, S. P.
(2004). Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. J. Gen. Virol.
85: 2023-2034
[Abstract]
[Full Text]
-
Kwiatkowski, B., Chen, S. Y. J., Schubach, W. H.
(2004). CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation. J. Virol.
78: 6067-6072
[Abstract]
[Full Text]
-
De Francesco, M. A., Gargiulo, F., Esteban, P., Calzavara-Pinton, P. G., Venturini, M., Perandin, F., Baronio, M., Pollara, C., Terlenghi, L., Manca, N.
(2004). Polymorphism analysis of Epstein-Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides. J Med Microbiol
53: 381-387
[Abstract]
[Full Text]
-
Thompson, M. P., Kurzrock, R.
(2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res.
10: 803-821
[Abstract]
[Full Text]
-
Kennedy, G., Komano, J., Sugden, B.
(2003). Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. USA
100: 14269-14274
[Abstract]
[Full Text]
-
Walling, D. M., Brown, A. L., Etienne, W., Keitel, W. A., Ling, P. D.
(2003). Multiple Epstein-Barr Virus Infections in Healthy Individuals. J. Virol.
77: 6546-6550
[Abstract]
[Full Text]
-
Sitki-Green, D., Edwards, R. H., Webster-Cyriaque, J., Raab-Traub, N.
(2002). Identification of Epstein-Barr Virus Strain Variants in Hairy Leukoplakia and Peripheral Blood by Use of a Heteroduplex Tracking Assay. J. Virol.
76: 9645-9656
[Abstract]
[Full Text]
-
Jenson, H. B., Ench, Y., Zhang, Y., Gao, S.-J., Arrand, J. R., Mackett, M.
(2002). Characterization of an Epstein-Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus). J. Gen. Virol.
83: 1621-1633
[Abstract]
[Full Text]
-
Higa, M, Kinjo, T, Kamiyama, K, Iwamasa, T, Hamada, T, Iyama, K
(2002). Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J. Clin. Pathol.
55: 414-423
[Abstract]
[Full Text]
-
Hille, A., Badu-Antwi, A., Holzer, D., Grasser, F. A.
(2002). Lysine residues of Epstein-Barr virus-encoded nuclear antigen 2 do not confer secondary modifications via ubiquitin or SUMO-like proteins but modulate transcriptional activation. J. Gen. Virol.
83: 1037-1042
[Abstract]
[Full Text]
-
Spender, L. C., Cornish, G. H., Sullivan, A., Farrell, P. J.
(2002). Expression of Transcription Factor AML-2 (RUNX3, CBF{alpha}-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype. J. Virol.
76: 4919-4927
[Abstract]
[Full Text]
-
Fielding, C. A., Sandvej, K., Mehl, A., Brennan, P., Jones, M., Rowe, M.
(2001). Epstein-Barr Virus LMP-1 Natural Sequence Variants Differ in Their Potential To Activate Cellular Signaling Pathways. J. Virol.
75: 9129-9141
[Abstract]
[Full Text]
-
Nakamura, H., Zarycki, J., Sullivan, J. L., Jung, J. U.
(2001). Abnormal T Cell Receptor Signal Transduction of CD4 Th Cells in X-Linked Lymphoproliferative Syndrome. J. Immunol.
167: 2657-2665
[Abstract]
[Full Text]
-
Salamon, D., Takacs, M., Ujvari, D., Uhlig, J., Wolf, H., Minarovits, J., Niller, H. H.
(2001). Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus. J. Virol.
75: 2584-2596
[Abstract]
[Full Text]
-
Young, L S, Dawson, C W, Eliopoulos, A G
(2000). The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol.
53: 238-247
[Abstract]
[Full Text]
-
Damania, B., Choi, J.-K., Jung, J. U.
(2000). Signaling Activities of Gammaherpesvirus Membrane Proteins. J. Virol.
74: 1593-1601
[Full Text]
-
Brooks, J. M., Croom-Carter, D. S. G., Leese, A. M., Tierney, R. J., Habeshaw, G., Rickinson, A. B.
(2000). Cytotoxic T-Lymphocyte Responses to a Polymorphic Epstein-Barr Virus Epitope Identify Healthy Carriers with Coresident Viral Strains. J. Virol.
74: 1801-1809
[Abstract]
[Full Text]
-
Midgley, R. S., Blake, N. W., Yao, Q. Y., Croom-Carter, D., Cheung, S. T., Leung, S. F., Chan, A. T. C., Johnson, P. J., Huang, D., Rickinson, A. B., Lee, S. P.
(2000). Novel Intertypic Recombinants of Epstein-Barr Virus in the Chinese Population. J. Virol.
74: 1544-1548
[Abstract]
[Full Text]
-
Cho, Y.-G., Gordadze, A. V., Ling, P. D., Wang, F.
(1999). Evolution of Two Types of Rhesus Lymphocryptovirus Similar to Type 1 and Type 2 Epstein-Barr Virus. J. Virol.
73: 9206-9212
[Abstract]
[Full Text]
-
van Baarle, D., Hovenkamp, E., Kersten, M. J., Klein, M. R., Miedema, F., van Oers, M. H.J.
(1999). Direct Epstein-Barr Virus (EBV) Typing on Peripheral Blood Mononuclear Cells: No Association Between EBV Type 2 Infection or Superinfection and the Development of Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma. Blood
93: 3949-3955
[Abstract]
[Full Text]
-
Zong, J.-C., Ciufo, D. M., Alcendor, D. J., Wan, X., Nicholas, J., Browning, P. J., Rady, P. L., Tyring, S. K., Orenstein, J. M., Rabkin, C. S., Su, I.-J., Powell, K. F., Croxson, M., Foreman, K. E., Nickoloff, B. J., Alkan, S., Hayward, G. S.
(1999). High-Level Variability in the ORF-K1 Membrane Protein Gene at the Left End of the Kaposi's Sarcoma-Associated Herpesvirus Genome Defines Four Major Virus Subtypes and Multiple Variants or Clades in Different Human Populations. J. Virol.
73: 4156-4170
[Abstract]
[Full Text]
-
Habeshaw, G., Yao, Q. Y., Bell, A. I., Morton, D., Rickinson, A. B.
(1999). Epstein-Barr Virus Nuclear Antigen 1 Sequences in Endemic and Sporadic Burkitt's Lymphoma Reflect Virus Strains Prevalent in Different Geographic Areas. J. Virol.
73: 965-975
[Abstract]
[Full Text]
-
Fuentes-Panana, E. M., Swaminathan, S., Ling, P. D.
(1999). Transcriptional Activation Signals Found in the Epstein-Barr Virus (EBV) Latency C Promoter Are Conserved in the Latency C Promoter Sequences from Baboon and Rhesus Monkey EBV-Like Lymphocryptoviruses (Cercopithicine Herpesviruses 12 and 15). J. Virol.
73: 826-833
[Abstract]
[Full Text]
-
Yao, Q. Y., Croom-Carter, D. S. G., Tierney, R. J., Habeshaw, G., Wilde, J. T., Hill, F. G. H., Conlon, C., Rickinson, A. B.
(1998). Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort. J. Virol.
72: 4352-4363
[Abstract]
[Full Text]
-
Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A., Ambinder, R. F.
(1998). Epstein-Barr Virus (EBV) in Endemic Burkitt's Lymphoma: Molecular Analysis of Primary Tumor Tissue. Blood
91: 1373-1381
[Abstract]
[Full Text]
-
Ometto, L., Menin, C., Masiero, S., Bonaldi, L., Del Mistro, A., Cattelan, A. M., D'Andrea, E., De Rossi, A., Chieco-Bianchi, L.
(1997). Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas. Blood
90: 313-322
[Abstract]
[Full Text]
-
Dolcetti, R., Zancai, P., De Re, V., Gloghini, A., Bigoni, B., Pivetta, B., De Vita, S., Carbone, A., Boiocchi, M.
(1997). Epstein-Barr Virus Strains With Latent Membrane Protein-1 Deletions: Prevalence in the Italian Population and High Association With Human Immunodeficiency Virus-Related Hodgkin's Disease. Blood
89: 1723-1731
[Abstract]
[Full Text]
Copyright © 1987 by the American Society for Microbiology. All rights reserved.